Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative ...

As interest rates fall, business development companies', or BDCs, return on equity will likely be pressured. Oppenheimer ...

Meeting to be held on April 3-4 hosted by Oppenheimer. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...